Abivax Pharma (ABVX) Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization
The ABIVAX (ABVX) EV/EBITDA chart demonstrates profit potential from the market launch of obefeximod for colitis. However, delays in final trials and long-term commercial threats are creating pressure, with the 0.00 level serving as a critical mark. Successful approval of unique drugs will allow the firm to exercise pricing power and set premium prices due to the absence of available analogs.
Abivax SA - analytical breakdowns and key metrics (ABVX)
- current price and projected stock value:
- market capitalization details:
- book value of equity indicators:
- debt level and financial liquidity data:
- business earnings and investment ratios data:
ABVX - Net Financial Result|Future Profit ABIVAX|ABVX - Price to Earnings Ratio|Forward P/E Multiple ABIVAX|ABVX - PEG Multiple|Enterprise Value to EBITDA Ratio Abivax Corp|ABVX - Operating profit before amortization|Net earnings per share (EPS TTM) Abivax|ABVX - Net earnings per share (EPS TTM)|Quarterly EPS earnings growth abivax.com|ABVX - Earnings per share growth in current year|Expected earnings per share growth for next year ABIVAX
Initial company analysis:Abivax Corp ABVX
Selecting reliable equity assets requires analyzing the resilience of business value relative to its operating profit. The ratio of total enterprise value to EBITDA, represented by the EV/EBITDA metric for ABIVAX (ABVX), allows for an assessment of the asset's premium, which is critical for a biotech firm with immense market potential for anti-inflammatory bowel disease drugs and a heavy dependence on clinical trial results.
Competitors of ABIVAX
EV/EBITDA Multiple ARGX (Argenx)|Total Company Value to Operating Income Before Depreciation Ratio BioNTech Pharma (BNTX)|ADMA - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|protagonist-inc.com (PTGX) - Enterprise Value to EBITDA Ratio|Immunovant (IMVT) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to EBITDA Ratio Kiniksa Pharmaceuticals, Ltd.|Enterprise Value to EBITDA Ratio GRFS|EV/EBITDA Multiple Adaptive Biotechnologies Inc.|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Celldex Therapeutics (CLDX)|auriniapharma.com - Enterprise Value to Operating Income Before Depreciation|EV/EBITDA Multiple BCRX (BioCryst Pharmaceuticals)|Vera Therapeutics Inc (VERA) - Company Value to EBITDA|Dianthus Pharma - EV/EBITDA Multiple|PHVS - EV/EBITDA Multiple|ABCL: EV/EBITDA Multiple|TRML (tourmalinebio.com) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|PGEN (Precigen) - EV/EBITDA Multiple|Pharming Group NV (PHAR) - Total Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to EBITDA Ratio NKTR (Nektar)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization UPB (Upstream Pharma)|EV/EBITDA Multiple ZBIO (Zenas Biopharma Inc)|EV/EBITDA Multiple immunome.com IMNM|GOSS: Enterprise Value to EBITDA Ratio|KALV (KalVista Pharma) - Enterprise Value to Operating Income Before Depreciation|SEPN: EV/EBITDA Multiple|Pieris Corp (PVLA) - EV/EBITDA Multiple|SVRA (Savara Inc.) - EV/EBITDA Multiple|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization RIGL|Enterprise Value to EBITDA Ratio ANAB (AnaptysBio)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization ATXS (Astria Therapeutics Inc)|enGene Bio - Enterprise Value to EBITDA Ratio|RAPT: Enterprise Value to Operating Income Before Depreciation|JBIO - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Company Value to Operating Income Before Depreciation Ratio ACRS|KYTX: EV/EBITDA Multiple|Tiziana Life Sciences Ltd. - Business Value to Operating Income Before Depreciation|CABA (Cabaletta Bio, Inc) - EV/EBITDA Multiple|EV/EBITDA Multiple Ventyx Biosciences, Inc|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Theratechnologies Inc. (THTX)|AVTX (avalotx.com) - Business Value to Operating Income Before Depreciation|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Eledon Pharmaceuticals, Inc. ELDN|AGEN - Enterprise Value to EBITDA Ratio|Climb Bio, Inc. - EV/EBITDA Multiple|ZURA - EV/EBITDA Multiple|ATYR (aTyr Pharma, Inc.) - Enterprise Value to EBITDA Ratio|Adagene Inc. - Business Value to Operating Income Before Depreciation|IMA (ImageneBio) - EV/EBITDA Multiple|Shattuck Therapeutics (STTK) - Total Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Equillium, Inc. (EQ)|Enterprise Value to EBITDA Ratio connectbiopharm.com CNTB|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Immunic IMUX|ATRA - Enterprise Value to EBITDA Ratio|IFRX: Enterprise Value to EBITDA Ratio|XFOR - EV/EBITDA Multiple|adicetbio.com (ACET) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to Operating Income Before Depreciation CELU|INMB (INmune Bio, Inc.) - EV/EBITDA Multiple|Company Value to EBITDA barinthusbio.com BRNS|EV/EBITDA Multiple KZR|EV/EBITDA Multiple SAB Biotherapeutics Inc. (SABS)|EV/EBITDA Multiple AKTX (Akari Therapeutics plc)|Enlivex Therapeutics Ltd - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Q32 Bio Corp - EV/EBITDA Multiple|Total Company Value to Operating Income Before Depreciation Ratio geovax.com GOVX|EDSA (Edesa Biotech) - Enterprise Value to EBITDA Ratio|IBIO (iBio Inc) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|CARM (Carisma Therapeutics Inc) - EV/EBITDA Multiple|EV/EBITDA Multiple XTL Bio|Enterprise Value to EBITDA Ratio BOLT (Bolt Biotherapeutics)|hcwbiologics.com - Enterprise Value to Operating Income Before Depreciation|EV/EBITDA Multiple APVO (Aptevo Therapeutics Inc.)|EV/EBITDA Multiple aimimmuno.com AIM|Aditxt Corp - EV/EBITDA Multiple|GRI: Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|XRTX (XORTX Therapeutics Inc.) - Enterprise Value to EBITDA Ratio|HIND (reshapelifesciences.com) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to EBITDA Ratio REVB|Enterprise Value to Operating Income Before Depreciation INDP (Indaptus Therapeutics Inc)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Scinai (SCNI)|CALI: Company Value to Operating Income Before Depreciation Ratio|EV/EBITDA Multiple AFMD (Affimed N.V.)|Business Value to Operating Income Before Depreciation ALLK|HOOKIPA - EV/EBITDA Multiple|IGMS - EV/EBITDA Multiple|iTeos (ITOS) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Ocean Biomedical Corp - Business Value to Operating Income Before Depreciation|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization TC Biopharm|Enterprise Value to EBITDA Ratio thirdharmonicbio.com (THRD)
